Search

everythinglearnresearchcommunity

for

Search:↓

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Mutations in certain receptors can cause diseases and offer new treatment options.

DHT stops hair regrowth in mice, similar to human hair loss.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Certain gene variations are linked to better memory in healthy Chinese women.

Certain gene variations might be linked to severe acne in women but not in men.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Certain Dibenzo derivatives may help treat prostate cancer.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.